Global Home Infusion Therapy Devices Market to reach USD 32.39 billion by 2027.Global Home Infusion Therapy Devices Market is valued approximately USD 18.3 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2021-2027. Home Infusion Therapy is a therapy which a person receives at home for the treatment of various diseases. Cost effectiveness of the therapy, more convenience for the patients are some factors driving the market. Along with that increase in the geriatric population with the preference for home care, less mobility serves as another driver for the market. Infusion devices are used to treat different diseases at home including cancer. The growing prevalence of hospital-acquired infections (HAIs) across institutions as a result of exposure to contaminated equipment, bed linens, and air droplets is also propelling market expansion. Furthermore, as the coronavirus illness (COVID-19) spreads throughout the world, there has been a substantial increase in demand for home infusion treatments to reduce the risk of infection and ensure effective therapy. According to the WHO, 19.3 million new cases of cancer were reported globally in 2020. Growing preference for home treatment will have a positive effect on the market. However, strict government regulation for manufacturers impedes the growth of the market over the forecast period of 2021-2027. Also, technological advancement in infusion therapy devices is likely to increase the market growth during the forecast period.

The regional analysis of global Home Infusion Therapy Devices Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to rising adoption of new technology in infusion pumps. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2021-2027. Factors such as rising awareness for the benefit of home infusion therapy over hospitals would create lucrative growth prospects for the Home Infusion Therapy Devices Market across Asia-Pacific region.

Major market player included in this report are:
CVS/Coram
Option Care Health
BriovaRx/Diplomat (UnitedHealth Optum)
PharMerica
Fresenius Kabi
ICU Medical, Inc.
B. Braun Melsungen AG
Baxter
BD
Caesarea Medical Electronics


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Infusion Pumps
Intravenous Sets
IV Cannulas
Needleless Connectors


By Application:
Anti-infective
Endocrinology
Hydration Therapy
Chemotherapy
Enteral Nutrition
Parenteral Nutrition
Specialty Pharmaceuticals
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Home Infusion Therapy Devices Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors